Why Approval Took Two Decades
7:36–8:57 · 81s
Michael lays out the costly, animal-testing-heavy U.S. drug pathway that makes sunscreen approvals far slower than in Europe or Asia, revealing DSM spent eighteen million dollars to clear BEMT.
7:36–8:57 · 81s
Michael lays out the costly, animal-testing-heavy U.S. drug pathway that makes sunscreen approvals far slower than in Europe or Asia, revealing DSM spent eighteen million dollars to clear BEMT.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.